XML 17 R7.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jul. 02, 2016
Jul. 04, 2015
Cash Flows From Operating Activities    
Net income (loss) $ 172,958 $ (1,340,707)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation of leasehold improvements and equipment 159,370 137,279
Amortization of intangibles 38,415 20,541
Share-based compensation expense 657,637 1,223,177
Allowance for doubtful trade receivables 29,649 3,365
Loss from disposal of equipment 18,226
Non-cash loss on debt extinguishment 32,007
Non-cash financing costs 94,080 92,143
Changes in operating assets and liabilities:    
Trade receivables (4,372,837) (1,195,891)
Inventories 3,628,678 645,308
Prepaid expenses and other assets (266,831) (134,482)
Accounts payable (3,892,582) (357,065)
Accrued expenses 634,562 427,913
Customer deposits and other (9,150) (5,251)
Deferred rent 106,657 (31,732)
Net cash used in operating activities (2,987,387) (497,176)
Cash Flows From Investing Activities    
Purchases of leasehold improvements and equipment (231,201) (139,162)
Purchases of intangible assets (195,000) (22,500)
Net cash used in investing activities (426,201) (161,662)
Cash Flows From Financing Activities    
Proceeds from issuance of common stock, net of issuance costs 5,720,000
Proceeds from exercise of stock options 622,384 15,601
Proceeds from loan payable 2,500,000
Payment of debt issuance cost (15,000)
Principal payments on loan payable (5,000,000)
Principal payments on capital leases (108,249) (107,265)
Net cash provided by financing activities 1,234,135 2,393,336
Net (decrease) increase in cash (2,179,453) 1,734,498
Cash Beginning of Period 5,549,672 3,964,750
Cash Ending of Period 3,370,219 5,699,248
Supplemental Disclosures of Cash Flow Information    
Cash payments for interest 239,839 73,202
Supplemental Schedule of Noncash Investing Activity    
Capital lease obligation incurred for purchases of equipment 303,933
Inventory supplied to Healthspan Research, LLC for equity interest, at cost 20,318
Retirement of fully depreciated equipment - cost 28,083
Retirement of fully depreciated equipment - accumulated depreciation $ (28,083)